Xarelto Lawsuit Plaintiff Claims Man Died Of Uncontrollable Bleeding Caused By Drug

June 06, 2016 – – TheProductLawyers.com reports on a lawsuit filed in the state of Vermont by the daughter of a deceased Xarelto user, her father. She claims he died from an uncontrollable brain bleed which was caused by his use of the drug when he sustained an injury.

In her lawsuit paperwork, the plaintiff claims her father was prescribed Xarelto to treat his atrial fibrillation, a heart condition that can sometimes put patients at risk for blood clots or stroke. Blood thinners, such as Xarelto, are used as a preventative option to prevent clotting or stroke. Her lawsuit has been filed against the makers of the drug, Bayer AG and Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation.

She further states in her court filing, that her father had only been using Xarelto for a brief period. After his fall and the brain bleeding occurred, he was diagnosed with an intracerebral hemorrhage. He eventually died from the bleeding.

Many blood thinners, such as warfarin, are accompanied with an antidote via the use of Vitamin K, which acts as to counter the effects of the blood thinner and allows blood to form clots. At the time of the plaintiff’s father’s death, there was no antidote released with Xarelto, leaving doctors with no option other than blood transfusions or surgery.

The plaintiff is claiming that the drug’s manufacturers were negligent in releasing a drug on the market with no known antidote, which can create potentially lethal bleeding dangers, as was the case with her father.

In addition to the plaintiff’s lawsuit, many others have been filed claiming the drug caused uncontrollable bleeding. 550 lawsuits have been consolidated into a mass tort program in Philadelphia, PA, along with 2,800 others that have been grouped together in a Multidistrict Litigation (MDL 2592).

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60010450